Biote Corp

NAS:BTMDHealthcarenasdaq_composite

$1.09+0.00%LiveIn session · ≈ AED 4.00 · Market cap $39.16M · Next earnings Wed 4 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	61.5%	65.0%	66.9%	68.8%	70.5%	71.5%	—	—
Operating margin	27.3%	24.8%	−36.8%	15.5%	16.0%	18.5%	18.5%	+0.0 pts
Net margin	25.0%	23.4%	−0.6%	1.8%	1.6%	14.1%	14.1%	+0.0 pts
EBITDA margin	28.2%	25.8%	4.8%	21.3%	7.9%	27.2%	—	—
Return on equity	−170.8%	790.8%	2.2%	−11.3%	−3.0%	−46.2%	−53.7%	−7.5 pts
Return on assets	89.5%	60.0%	−0.9%	2.1%	2.6%	25.1%	25.1%	+0.0 pts
Return on capital employed	152.2%	93.4%	−65.4%	21.5%	44.6%	56.8%	—	—
Debt / equity	−2.5×	9.1×	−2.7×	−3.9×	−1.0×	−1.9×	−2.2×	−16.2%
Debt / assets	130.0%	68.7%	107.9%	74.0%	90.6%	102.1%	—	—
Interest coverage	13.1×	20.7×	−15.0×	4.5×	2.9×	3.2×	—	—
Current ratio	2.4×	2.7×	5.4×	5.5×	1.3×	1.2×	1.2×	+0.0%
Quick ratio	2.0×	2.2×	4.8×	4.7×	1.0×	0.8×	—	—
Cash ratio	1.5×	1.5×	4.2×	4.0×	0.8×	0.5×	0.5×	+0.0%
Asset turnover	3.6×	2.6×	1.5×	1.2×	1.6×	1.8×	—	—
Inventory turnover	10.4×	5.1×	4.9×	3.3×	3.9×	2.9×	—	—
Receivables turnover	24.7×	26.6×	23.7×	22.7×	25.6×	25.0×	—	—
Dividend payout	45.7%	35.0%	−1,329.8%	262.2%	150.3%	6.4%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.